PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Drug Regulatory-compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product – With a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues
Schröder, H.M.; Niebergall-Roth, E.; Norrick, A.; Esterlechner, J.; Ganss, C.; Frank, M.H.; Kluth, M.A. Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. Cells2023, 12, 1788.
Schröder, H.M.; Niebergall-Roth, E.; Norrick, A.; Esterlechner, J.; Ganss, C.; Frank, M.H.; Kluth, M.A. Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. Cells 2023, 12, 1788.
Schröder, H.M.; Niebergall-Roth, E.; Norrick, A.; Esterlechner, J.; Ganss, C.; Frank, M.H.; Kluth, M.A. Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. Cells2023, 12, 1788.
Schröder, H.M.; Niebergall-Roth, E.; Norrick, A.; Esterlechner, J.; Ganss, C.; Frank, M.H.; Kluth, M.A. Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues. Cells 2023, 12, 1788.
Abstract
Quantitative polymerase chain reaction (qPCR) has emerged as an important bioanalytical method for assessing the pharmacokinetics of human cell-based medicinal products after xenotransplantation into immunodeficient mice. A particular challenge in bioanalytical qPCR studies is that the different tissues of the host organism can affect amplification efficiency and amplicon detection to varying degrees, and ignoring these matrix effects can easily cause a significant underestimation of the true number of target cells in a sample. Here we describe the development and drug regulatory-compliant validation of a TaqMan® qPCR assay for quantification of mesenchymal stromal cells in the range of 125 to 20,000 cells/200 µl lysate by amplification of a human-specific, highly repetitive αsatellite DNA sequence of the chromosome 17 centromere region HSSATA17. Assessment of matrix effects in 14 different mouse tissues and blood revealed a wide range of spike recovery rates across the different tissue types from 11 to 174%. Based on these observations, we propose to perform systematic spike-and-recovery experiments during assay validation and to correct for the effects of the different tissue matrices on cell quantification in subsequent bioanalytical studies by multiplying the back-calculated cell number by tissue-specific factors derived from the inverse of the validated percent recovery rate.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
*
